CLBX — Cellbxhealth Share News
0.000.00%
Last trade - 00:00- £9.40m
- £7.84m
- £1.35m
Brief: Angle Appoints Jan Groen As Executive Chairman
Strategy Update
Presentation of Data on Glioblastoma
Brief: Angle's CEO Andrew Newland & Finance Director Ian Griffiths To Step Down From Board
Board Changes
Brief: Angle H1 Pretax Profit GBP -9.732 Million
Interim Results
Notice of Results
PARSORTIX ENABLES STUDY OF CANCER PROGRESSION
EACR 2025: Innovation in AR expression profiling
EACR 2025: Data demonstrating DNA dual analysis
Novel discoveries into the biology of cancer
POSTING OF ANNUAL REPORT AND NOTICE OF AGM
Brief: Angle Announces Reviewing Board Structure And Composition
Board Changes
Brief: Angle PLC Sees Cash Runway Into Q1 2026
Preliminary Results
Notice of Results
RESULTS SUPPORTING ANGLE’S HER2 ASSAY PROGRAMME